News and Announcements
OncoSil Appoints Michael Warrener as Global Sales and Marketing Director
- Published May 18, 2016 10:45AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
18th May 2016, ASX Announcement
OncoSil Medical Limited (ASX: OSL) (OncoSil Medical or the Company) is pleased to announce the appointment of Mr Michael Warrener as Global Sales and Marketing Director. Mr Warrener will be responsible for implementing the Company’s commercialisation strategy and infrastructure.
Mr Warrener will be based in Sydney and will oversee the initial market launch in Europe, Australia and key Asian markets. Mr Warrener will commence his role on 1st of June and his appointment completes the Senior Leadership Team of the Company.
Mr Warrener has forged a highly successful career in the pharmaceutical and medical device sector over a period of more than 23 years, including eight years with Sirtex Medical Ltd (ASX: SRX). During his time with Sirtex he held a number of senior management roles including Sales and Marketing Director for Europe and Middle East where he helped introduce then drive adoption of the Sir-Spheres product in the Australian, European Union and Middle East markets.
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
